ID   PIN4_HUMAN              Reviewed;         131 AA.
AC   Q9Y237; A8E0G6; B3KXM0; F5H1P5; Q0D2H3; Q3MHV0; Q52M21; Q5HYW6;
AC   Q6IRW4;
DT   23-JAN-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   15-MAR-2017, entry version 147.
DE   RecName: Full=Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4;
DE            EC=5.2.1.8;
DE   AltName: Full=Parvulin-14;
DE            Short=Par14;
DE            Short=hPar14;
DE   AltName: Full=Parvulin-17;
DE            Short=Par17;
DE            Short=hPar17;
DE   AltName: Full=Peptidyl-prolyl cis-trans isomerase Pin4;
DE            Short=PPIase Pin4;
DE   AltName: Full=Peptidyl-prolyl cis/trans isomerase EPVH;
DE            Short=hEPVH;
DE   AltName: Full=Rotamase Pin4;
GN   Name=PIN4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=10364457; DOI=10.1006/bbrc.1999.0828;
RA   Rulten S.L., Thorpe J.R., Kay J.E.;
RT   "Identification of eukaryotic parvulin homologues: a new subfamily of
RT   peptidylprolyl cis-trans isomerases.";
RL   Biochem. Biophys. Res. Commun. 259:557-562(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=10100858; DOI=10.1016/S0014-5793(99)00239-2;
RA   Uchida T., Fujimori F., Tradler T., Fischer G., Rahfeld J.-U.;
RT   "Identification and characterization of a 14 kDa human protein as a
RT   novel parvulin-like peptidyl prolyl cis/trans isomerase.";
RL   FEBS Lett. 446:278-282(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND
RP   VARIANTS GLN-16 AND ARG-18 (ISOFORM 2).
RC   TISSUE=Brain, Prostate, and Urinary bladder;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-13 (ISOFORM 1), PARTIAL NUCLEOTIDE
RP   SEQUENCE [MRNA] (ISOFORM 2), ALTERNATIVE PROMOTER USAGE, SUMOYLATION,
RP   TISSUE SPECIFICITY, AND VARIANTS GLN-16 AND ARG-18 (ISOFORM 2).
RX   PubMed=16522211; DOI=10.1186/1471-2199-7-9;
RA   Mueller J.W., Kessler D., Neumann D., Stratmann T., Papatheodorou P.,
RA   Hartmann-Fatu C., Bayer P.;
RT   "Characterization of novel elongated Parvulin isoforms that are
RT   ubiquitously expressed in human tissues and originate from alternative
RT   transcription initiation.";
RL   BMC Mol. Biol. 7:9-9(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-6 AND 48-72, ALTERNATIVE
RP   PROMOTER USAGE (ISOFORMS 1 AND 2), DNA-BINDING, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=17875217; DOI=10.1186/1741-7007-5-37;
RA   Kessler D., Papatheodorou P., Stratmann T., Dian E.A.,
RA   Hartmann-Fatu C., Rassow J., Bayer P., Mueller J.W.;
RT   "The DNA binding parvulin Par17 is targeted to the mitochondrial
RT   matrix by a recently evolved prepeptide uniquely present in
RT   Hominidae.";
RL   BMC Biol. 5:37-37(2007).
RN   [7]
RP   PROTEIN SEQUENCE OF 15-25, IDENTIFICATION BY MASS SPECTROMETRY,
RP   PHOSPHORYLATION AT SER-19, MUTAGENESIS OF SER-19, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=12860119; DOI=10.1016/S0022-2836(03)00713-7;
RA   Reimer T., Weiwad M., Schierhorn A., Ruecknagel P.-K., Rahfeld J.-U.,
RA   Bayer P., Fischer G.;
RT   "Phosphorylation of the N-terminal domain regulates subcellular
RT   localization and DNA binding properties of the peptidyl-prolyl
RT   cis/trans isomerase hPar14.";
RL   J. Mol. Biol. 330:955-966(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 19-131 (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [9]
RP   DNA-BINDING, AND SUBCELLULAR LOCATION.
RX   PubMed=12144781; DOI=10.1016/S0022-2836(02)00615-0;
RA   Surmacz T.A., Bayer E., Rahfeld J.-U., Fischer G., Bayer P.;
RT   "The N-terminal basic domain of human parvulin hPar14 is responsible
RT   for the entry to the nucleus and high-affinity DNA-binding.";
RL   J. Mol. Biol. 321:235-247(2002).
RN   [10]
RP   FUNCTION, IDENTIFICATION IN PRE-RRNP COMPLEXES, PHOSPHORYLATION, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=19369196; DOI=10.1074/mcp.M900147-MCP200;
RA   Fujiyama-Nakamura S., Yoshikawa H., Homma K., Hayano T.,
RA   Tsujimura-Takahashi T., Izumikawa K., Ishikawa H., Miyazawa N.,
RA   Yanagida M., Miura Y., Shinkawa T., Yamauchi Y., Isobe T.,
RA   Takahashi N.;
RT   "Parvulin (Par14), a peptidyl-prolyl cis-trans isomerase, is a novel
RT   rRNA processing factor that evolved in the metazoan lineage.";
RL   Mol. Cell. Proteomics 8:1552-1565(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [13]
RP   STRUCTURE BY NMR OF 36-131.
RX   PubMed=10966801; DOI=10.1006/jmbi.2000.4013;
RA   Sekerina E., Rahfeld J.-U., Mueller J., Fanghaenel J., Rascher C.,
RA   Fischer G., Bayer P.;
RT   "NMR solution structure of hPar14 reveals similarity to the peptidyl
RT   prolyl cis/trans isomerase domain of the mitotic regulator hPin1 but
RT   indicates a different functionality of the protein.";
RL   J. Mol. Biol. 301:1003-1017(2000).
RN   [14]
RP   STRUCTURE BY NMR OF 28-131.
RX   PubMed=11162102; DOI=10.1006/jmbi.2000.4293;
RA   Terada T., Shirouzu M., Fukumori Y., Fujimori F., Ito Y., Kigawa T.,
RA   Yokoyama S., Uchida T.;
RT   "Solution structure of the human parvulin-like peptidyl prolyl
RT   cis/trans isomerase, hPar14.";
RL   J. Mol. Biol. 305:917-926(2001).
CC   -!- FUNCTION: Isoform 1 is involved as a ribosomal RNA processing
CC       factor in ribosome biogenesis. Binds to tightly bent AT-rich
CC       stretches of double-stranded DNA. {ECO:0000269|PubMed:19369196}.
CC   -!- FUNCTION: Isoform 2 binds to double-stranded DNA.
CC       {ECO:0000269|PubMed:19369196}.
CC   -!- CATALYTIC ACTIVITY: Peptidylproline (omega=180) = peptidylproline
CC       (omega=0).
CC   -!- SUBUNIT: Isoform 1 is found in pre-ribosomal ribonucleoprotein
CC       (pre-rRNP) complexes. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q9P209:CEP72; NbExp=3; IntAct=EBI-714599, EBI-739498;
CC       Q8IZU0:FAM9B; NbExp=3; IntAct=EBI-714599, EBI-10175124;
CC       Q969F0:FATE1; NbExp=3; IntAct=EBI-714599, EBI-743099;
CC       P43364-2:MAGEA11; NbExp=3; IntAct=EBI-714599, EBI-10178634;
CC       Q8ND90:PNMA1; NbExp=3; IntAct=EBI-714599, EBI-302345;
CC       Q96C00:ZBTB9; NbExp=3; IntAct=EBI-714599, EBI-395708;
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Nucleus, nucleolus. Cytoplasm,
CC       cytoskeleton, spindle. Cytoplasm. Note=Colocalizes in the
CC       nucleolus during interphase and on the spindle apparatus during
CC       mitosis with NPM1.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Mitochondrion. Mitochondrion
CC       matrix. Note=Imported in a time- and membrane potential-dependent
CC       manner to the mitochondrial matrix, but without concomitant
CC       processing of the protein. Directed to mitochondria by a novel N-
CC       terminal domain that functions as non-cleavable mitochondrial
CC       targeting peptide.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9Y237-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y237-2; Sequence=VSP_037754;
CC         Note=The first 25 amino acids are sufficient for mitochondrial
CC         targeting. Variant in position: 16:R->Q (in dbSNP:rs6525589).
CC         Variant in position: 18:S->R (in dbSNP:rs7058353).
CC         {ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:16522211};
CC       Name=3;
CC         IsoId=Q9Y237-3; Sequence=VSP_037754, VSP_046122;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Isoform 2 is much more stable than isoform 1
CC       (at protein level). Ubiquitous. Isoform 1 and isoform 2 are
CC       expressed in kidney, liver, blood vessel, brain, mammary gland,
CC       skeletal muscle, small intestine and submandibularis. Isoform 1
CC       transcripts are much more abundant than isoform 2 in each tissue
CC       analyzed. {ECO:0000269|PubMed:10100858,
CC       ECO:0000269|PubMed:10364457, ECO:0000269|PubMed:16522211}.
CC   -!- DOMAIN: The PPIase domain enhances mitochondrial targeting.
CC   -!- PTM: Phosphorylated. Isoform 1 phosphorylation occurs both in the
CC       nucleus and the cytoplasm. Isoform 1 phosphorylation at Ser-19
CC       does not affect its PPIase activity but is required for nuclear
CC       localization, and the dephosphorylation is a prerequisite for the
CC       binding to DNA. The unphosphorylated isoform 1 associates with the
CC       pre-rRNP complexes in the nucleus. {ECO:0000269|PubMed:12860119,
CC       ECO:0000269|PubMed:19369196}.
CC   -!- PTM: Isoform 2 is sumoylated with SUMO2 and SUMO3.
CC       {ECO:0000269|PubMed:16522211}.
CC   -!- SIMILARITY: Belongs to the PpiC/parvulin rotamase family. PIN4
CC       subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH05234.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAH70288.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAI04654.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAI11395.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=BAG54532.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF143096; AAD27893.1; -; mRNA.
DR   EMBL; AB009690; BAA82320.1; -; mRNA.
DR   EMBL; BX119917; CAI39856.1; -; Genomic_DNA.
DR   EMBL; AL135749; CAI39856.1; JOINED; Genomic_DNA.
DR   EMBL; BC005234; AAH05234.2; ALT_INIT; mRNA.
DR   EMBL; BC070288; AAH70288.1; ALT_INIT; mRNA.
DR   EMBL; BC093700; AAH93700.1; -; mRNA.
DR   EMBL; BC104653; AAI04654.1; ALT_INIT; mRNA.
DR   EMBL; BC111394; AAI11395.1; ALT_INIT; mRNA.
DR   EMBL; BC112281; AAI12282.1; -; mRNA.
DR   EMBL; AM420633; CAM12362.1; -; Genomic_DNA.
DR   EMBL; AK127605; BAG54532.1; ALT_INIT; mRNA.
DR   CCDS; CCDS14417.1; -. [Q9Y237-2]
DR   CCDS; CCDS55447.1; -. [Q9Y237-3]
DR   RefSeq; NP_001164218.1; NM_001170747.1. [Q9Y237-3]
DR   RefSeq; NP_006214.2; NM_006223.3. [Q9Y237-2]
DR   UniGene; Hs.655623; -.
DR   PDB; 1EQ3; NMR; -; A=36-131.
DR   PDB; 1FJD; NMR; -; A=28-131.
DR   PDB; 3UI4; X-ray; 0.80 A; A=36-131.
DR   PDB; 3UI5; X-ray; 1.40 A; A=36-131.
DR   PDB; 3UI6; X-ray; 0.89 A; A=36-131.
DR   PDBsum; 1EQ3; -.
DR   PDBsum; 1FJD; -.
DR   PDBsum; 3UI4; -.
DR   PDBsum; 3UI5; -.
DR   PDBsum; 3UI6; -.
DR   ProteinModelPortal; Q9Y237; -.
DR   SMR; Q9Y237; -.
DR   BioGrid; 111320; 33.
DR   DIP; DIP-50838N; -.
DR   IntAct; Q9Y237; 16.
DR   STRING; 9606.ENSP00000362773; -.
DR   BindingDB; Q9Y237; -.
DR   ChEMBL; CHEMBL4923; -.
DR   iPTMnet; Q9Y237; -.
DR   PhosphoSitePlus; Q9Y237; -.
DR   DMDM; 20139299; -.
DR   EPD; Q9Y237; -.
DR   PaxDb; Q9Y237; -.
DR   PeptideAtlas; Q9Y237; -.
DR   PRIDE; Q9Y237; -.
DR   TopDownProteomics; Q9Y237-1; -. [Q9Y237-1]
DR   TopDownProteomics; Q9Y237-2; -. [Q9Y237-2]
DR   DNASU; 5303; -.
DR   Ensembl; ENST00000373669; ENSP00000362773; ENSG00000102309. [Q9Y237-2]
DR   Ensembl; ENST00000423432; ENSP00000409154; ENSG00000102309. [Q9Y237-3]
DR   GeneID; 5303; -.
DR   KEGG; hsa:5303; -.
DR   UCSC; uc004eam.4; human. [Q9Y237-1]
DR   CTD; 5303; -.
DR   DisGeNET; 5303; -.
DR   GeneCards; PIN4; -.
DR   H-InvDB; HIX0016866; -.
DR   HGNC; HGNC:8992; PIN4.
DR   HPA; HPA054483; -.
DR   HPA; HPA064504; -.
DR   MIM; 300252; gene.
DR   neXtProt; NX_Q9Y237; -.
DR   OpenTargets; ENSG00000102309; -.
DR   PharmGKB; PA33324; -.
DR   eggNOG; KOG3258; Eukaryota.
DR   eggNOG; COG0760; LUCA.
DR   GeneTree; ENSGT00510000047029; -.
DR   HOVERGEN; HBG019150; -.
DR   InParanoid; Q9Y237; -.
DR   KO; K09579; -.
DR   OMA; CEKEAKL; -.
DR   OrthoDB; EOG091G0Z6N; -.
DR   PhylomeDB; Q9Y237; -.
DR   TreeFam; TF101102; -.
DR   ChiTaRS; PIN4; human.
DR   EvolutionaryTrace; Q9Y237; -.
DR   GeneWiki; PIN4; -.
DR   GenomeRNAi; 5303; -.
DR   PRO; PR:Q9Y237; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000102309; -.
DR   CleanEx; HS_PIN4; -.
DR   ExpressionAtlas; Q9Y237; baseline and differential.
DR   Genevisible; Q9Y237; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005759; C:mitochondrial matrix; IDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0030684; C:preribosome; IDA:UniProtKB.
DR   GO; GO:0005819; C:spindle; IDA:UniProtKB.
DR   GO; GO:0003681; F:bent DNA binding; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0003690; F:double-stranded DNA binding; IDA:UniProtKB.
DR   GO; GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IEA:UniProtKB-KW.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0006364; P:rRNA processing; IMP:UniProtKB.
DR   InterPro; IPR000297; PPIase_PpiC.
DR   PROSITE; PS50198; PPIC_PPIASE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative promoter usage; Complete proteome;
KW   Cytoplasm; Cytoskeleton; Direct protein sequencing; DNA-binding;
KW   Isomerase; Mitochondrion; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Rotamase; Ubl conjugation.
FT   CHAIN         1    131       Peptidyl-prolyl cis-trans isomerase NIMA-
FT                                interacting 4.
FT                                /FTId=PRO_0000193438.
FT   DOMAIN       35    129       PpiC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00278}.
FT   REGION        1     41       Necessary for association with the pre-
FT                                rRNP complexes.
FT   REGION        1     25       Necessary for nuclear localization and
FT                                DNA-binding.
FT   MOD_RES      19     19       Phosphoserine; by CK2.
FT                                {ECO:0000269|PubMed:12860119}.
FT   VAR_SEQ       1      1       M -> MPMAGLLKGLVRQLERFSVQQQASKM (in
FT                                isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_037754.
FT   VAR_SEQ      80    131       GDLGWMTRGSMVGPFQEAAFALPVSGMDKPVFTDPPVKTKF
FT                                GYHIIMVEGRK -> IPSLQQHAGHHRDLRSTLISLVSYLQ
FT                                TTP (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046122.
FT   MUTAGEN      19     19       S->A: Abolishes phosphorylation and
FT                                reduces strongly nuclear localization.
FT                                {ECO:0000269|PubMed:12860119}.
FT   MUTAGEN      19     19       S->E: Does not abolish nuclear
FT                                localization and reduces DNA-binding
FT                                ability. {ECO:0000269|PubMed:12860119}.
FT   STRAND       37     47       {ECO:0000244|PDB:3UI4}.
FT   HELIX        48     59       {ECO:0000244|PDB:3UI4}.
FT   HELIX        64     71       {ECO:0000244|PDB:3UI4}.
FT   STRAND       73     75       {ECO:0000244|PDB:3UI4}.
FT   HELIX        76     78       {ECO:0000244|PDB:3UI4}.
FT   STRAND       81     86       {ECO:0000244|PDB:3UI4}.
FT   HELIX        92     99       {ECO:0000244|PDB:3UI4}.
FT   TURN        108    110       {ECO:0000244|PDB:1EQ3}.
FT   STRAND      116    118       {ECO:0000244|PDB:3UI4}.
FT   STRAND      121    130       {ECO:0000244|PDB:3UI4}.
SQ   SEQUENCE   131 AA;  13810 MW;  787C15BDB0701258 CRC64;
     MPPKGKSGSG KAGKGGAASG SDSADKKAQG PKGGGNAVKV RHILCEKHGK IMEAMEKLKS
     GMRFNEVAAQ YSEDKARQGG DLGWMTRGSM VGPFQEAAFA LPVSGMDKPV FTDPPVKTKF
     GYHIIMVEGR K
//
